Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Debaveye

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Antibiotics (Basel, Switzerland)|April 28, 2023
External Validation of the Augmented Renal Clearance Predictor in Critically Ill COVID-19 PatientsChao-Yuan Huang, Fabian Güiza, Matthias Gijsen, et al.
European Heart Journal|April 13, 2006
Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-lifeCatherine Ingels, Yves Debaveye, Ilse Milants, et al.
Mycoses|May 8, 2021
Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokineticsRuth Van Daele, Yves Debaveye, Robin Vos, et al.
Intensive Care Medicine|January 24, 2020
Five-year impact of ICU-acquired neuromuscular complications: a prospective, observational studyNathalie Van Aerde, Philippe Meersseman, Yves Debaveye, et al.
Thorax|March 13, 2021
Five-year outcome of respiratory muscle weakness at intensive care unit discharge: secondary analysis of a prospective cohort studyNathalie Van Aerde, Philippe Meersseman, Yves Debaveye, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2021
Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenationRuth Van Daele, Roger J Brüggemann, Erwin Dreesen, et al.
Hepatology (Baltimore, Md.)|November 12, 2013
Withholding parenteral nutrition during critical illness increases plasma bilirubin but lowers the incidence of biliary sludgeYoo-Mee Vanwijngaerden, Lies Langouche, Richard Brunner, et al.
Critical Care (London, England)|August 4, 2019
The soluble mannose receptor (sMR/sCD206) in critically ill patients with invasive fungal infections, bacterial infections or non-infectious inflammation: a secondary analysis of the EPaNIC RCTGreet De Vlieger, Ilse Vanhorebeek, Pieter J Wouters, et al.
Pharmaceutics|July 27, 2022
Systematic Comparison of Hospital-Wide Standard and Model-Based Therapeutic Drug Monitoring of Vancomycin in AdultsHeleen Gastmans, Erwin Dreesen, Sebastian G Wicha, et al.
Thorax|September 5, 2019
Five-year mortality and morbidity impact of prolonged versus brief ICU stay: a propensity score matched cohort studyGreet Hermans, Nathalie Van Aerde, Philippe Meersseman, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Antibiotics (Basel, Switzerland)|April 28, 2023
External Validation of the Augmented Renal Clearance Predictor in Critically Ill COVID-19 PatientsChao-Yuan Huang, Fabian Güiza, Matthias Gijsen, et al.
European Heart Journal|April 13, 2006
Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-lifeCatherine Ingels, Yves Debaveye, Ilse Milants, et al.
Mycoses|May 8, 2021
Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokineticsRuth Van Daele, Yves Debaveye, Robin Vos, et al.
Intensive Care Medicine|January 24, 2020
Five-year impact of ICU-acquired neuromuscular complications: a prospective, observational studyNathalie Van Aerde, Philippe Meersseman, Yves Debaveye, et al.
Thorax|March 13, 2021
Five-year outcome of respiratory muscle weakness at intensive care unit discharge: secondary analysis of a prospective cohort studyNathalie Van Aerde, Philippe Meersseman, Yves Debaveye, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2021
Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenationRuth Van Daele, Roger J Brüggemann, Erwin Dreesen, et al.
Hepatology (Baltimore, Md.)|November 12, 2013
Withholding parenteral nutrition during critical illness increases plasma bilirubin but lowers the incidence of biliary sludgeYoo-Mee Vanwijngaerden, Lies Langouche, Richard Brunner, et al.
Critical Care (London, England)|August 4, 2019
The soluble mannose receptor (sMR/sCD206) in critically ill patients with invasive fungal infections, bacterial infections or non-infectious inflammation: a secondary analysis of the EPaNIC RCTGreet De Vlieger, Ilse Vanhorebeek, Pieter J Wouters, et al.
Pharmaceutics|July 27, 2022
Systematic Comparison of Hospital-Wide Standard and Model-Based Therapeutic Drug Monitoring of Vancomycin in AdultsHeleen Gastmans, Erwin Dreesen, Sebastian G Wicha, et al.
Thorax|September 5, 2019
Five-year mortality and morbidity impact of prolonged versus brief ICU stay: a propensity score matched cohort studyGreet Hermans, Nathalie Van Aerde, Philippe Meersseman, et al.
Pageof 11